Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma. Kwon M, Iacoboni G, Reguera JL, Corral LL, et al. Haematologica 2022 Jun 30. doi: 10.3324/haematol.2022.280805.

Read + Share

Amedeo Smart

Independent Medical Education

Kwon M, Iacoboni G, Reguera JL, Corral LL, et al. Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma. Haematologica 2022 Jun 30. doi: 10.3324/haematol.2022.280805.
PMID: 35770532